GlassScriptPhysician profile
Anthony N Acello
NPI 1184628018
$2,683.91
in general payments reported to CMS, 2019-2025
27 companies · $874 in 2025
The $874 reported for 2025 was more than what 78% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $11.15 · 2021: $71.45 · 2022: $378 · 2023: $651 · 2024: $468 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $670.11 | 2019-2025 | Asnis, Easyfuse, Ortholoc 3di Crosscheck |
| Paratek Pharmaceuticals, INC. | $335.99 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $197.57 | 2022-2025 | Grafix Pl, Regranex, Collagenase Santyl |
| Treace Medical Concepts, INC. | $184.34 | 2023-2025 | |
| Zyla Life Sciences, INC. | $155.88 | 2019 | |
| Zimmer Biomet Holdings, INC. | $134.06 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $131.30 | 2023-2025 | Jublia |
| Medtronic, INC. | $127.32 | 2022 | |
| Amgen INC. | $99.36 | 2024-2025 | Krystexxa |
| Globus Medical, INC. | $93.45 | 2023-2025 | Ankle Fracture System, Senza |
| Orthofix Medical, INC. | $64.80 | 2024-2025 | Physio-Stim |
| Averitas Pharma INC. | $54.12 | 2023-2025 | Qutenza |
| Cardiovascular Systems INC. | $46.70 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $36.79 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $35.87 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $35.79 | 2020-2022 | |
| Sebela Pharmaceuticals INC. | $35.05 | 2023 | Naftin |
| Bone Support INC. | $33.85 | 2025 | Cerament G, Ceramentbone Void Filler |
| Convatec INC. | $32.91 | 2023 | |
| Kerecis Limited | $29.59 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $29.21 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $26.49 | 2024 | Arista Ah Flexitip |
| Merck Sharp & Dohme LLC | $24.89 | 2019 | |
| Seapearl East, INC | $20.41 | 2024 | |
| Bioventus LLC | $17.11 | 2023 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $15.66 | 2025 | Motoband |
| Grt US Holding, INC. | $15.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Acello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.